Literature DB >> 21391075

Building on community assets to improve palliative and end-of-life care.

Judith Dobrof1, Janna C Heyman, Reva M Greenberg.   

Abstract

In this article, the authors describe the development of a multidisciplinary, interfaith, grassroots community group of professionals and laypersons who have created a replicable model to enhance palliative and end-of-life care. The Collaborative for Palliative Care leverages existing community assets and capacities within the health and social service programs of Westchester County, New York, resulting in a unique public-private partnership. It has played a critical role in changing the culture of care for residents of Westchester who are faced with the challenges of serious and terminal illness.

Mesh:

Year:  2011        PMID: 21391075     DOI: 10.1080/15524256.2011.548044

Source DB:  PubMed          Journal:  J Soc Work End Life Palliat Care        ISSN: 1552-4264


  4 in total

1.  Development of a Community-Based Palliative Care Screening Tool for Underserved Older Adults With Chronic Illnesses.

Authors:  Angela Ghesquiere; Daniel S Gardner; Caitlin McAfee; Cara Kenien; Elizabeth Capezuti; Elissa Kozlov; Jo Anne Sirey; M Carrington Reid
Journal:  Am J Hosp Palliat Care       Date:  2018-01-03       Impact factor: 2.500

2.  Expanding palliative care's reach in the community via the elder service agency network.

Authors:  M Carrington Reid; Angela Ghesquiere; Cara Kenien; Elizabeth Capezuti; Daniel Gardner
Journal:  Ann Palliat Med       Date:  2017-04-17

3.  Associations of participation in community assets with health-related quality of life and healthcare usage: a cross-sectional study of older people in the community.

Authors:  Luke A Munford; Mark Sidaway; Amy Blakemore; Matt Sutton; Pete Bower
Journal:  BMJ Open       Date:  2017-02-09       Impact factor: 2.692

4.  Effects of participating in community assets on quality of life and costs of care: longitudinal cohort study of older people in England.

Authors:  Luke Aaron Munford; Anna Wilding; Peter Bower; Matt Sutton
Journal:  BMJ Open       Date:  2020-02-06       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.